Abcam
ExitedA producer and distributor of research-grade antibodies and associated products
Abcam has raised €1.3M across 1 funding round, most recently a Early VC round in Jun 2011. Based in Cambridge, UK; founded 1998; active in Healthtech. Acquired by Danaher in 2023. Data as of 28 Oct 2026.
Total raised
€1.3M
€1,251,303
Funding rounds
1
Investors
0
distinct backers
Active since
2011-06
latest 2011-06
Funding by year
EUR raised per yearAbcam — funding by year — interactive chart.
Data table
| Abcam — funding by year | |
|---|---|
| 2011 | €1.3M |
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2011-06-01 | Early VC | €1.3M | — | View deal → |
Exit
Type
acquisition
Date
Aug 2023
Value
€5.2B
Acquiror
Danaher (United States of America)